Promonitor® Quick
Promonitor Quick ANTI-IFX Test is a fully decentralized Real Point-of-Care test used to monitor the effectivity of biological treatment carried out with Infliximab (Remicade/Remsima/Inflectra).
Generelt
Promonitor Quick ANTI-IFX Test measures the anti-drug antibody level for Infliximab from whole blood or serum sample in just 30 minutes facilitating immediate decisions about treatment management.
Promonitor Quick provides you with
- Rapid identification of an inappropriate reaction to the biologic treatment
- Ability to avoid infusion related reactions
- Reliable and high precision results
Tekniske data
| Products available |
|
| Use | For in vitro diagnostic use |
| Method | Rapid immunochromatography |
| Sample types | Whole blood or serum |
| Time to result | 30 minutes |
| Reading of the result | Visually or instrument read |
| Limit of Detection | 23 AU/mL (visual) |
| Storage | 18-25°C , do not freeze |
Ytterligere informasjon
More information about Promonitor® tests is available at: http://www.diagnostic.grifols.com/promonitor-quick